Cargando…

Person-based co-design of a decision aid template for people with a genetic predisposition to cancer

BACKGROUND: People with genetic predispositions to cancer are faced with complex health decisions about managing their risk. Decision aids can support informed, values-based decisions, alongside shared decision-making with a clinician. Whilst diagnoses of genetic predispositions to cancer are increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Kate, Kohut, Kelly, Turner, Lesley, Smith, Sian, Crosbie, Emma J., Ryan, Neil, Grimmett, Chloe, Eccles, Diana M., Foster, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743799/
https://www.ncbi.nlm.nih.gov/pubmed/36518561
http://dx.doi.org/10.3389/fdgth.2022.1039701
_version_ 1784848801162330112
author Morton, Kate
Kohut, Kelly
Turner, Lesley
Smith, Sian
Crosbie, Emma J.
Ryan, Neil
Grimmett, Chloe
Eccles, Diana M.
Foster, Claire
author_facet Morton, Kate
Kohut, Kelly
Turner, Lesley
Smith, Sian
Crosbie, Emma J.
Ryan, Neil
Grimmett, Chloe
Eccles, Diana M.
Foster, Claire
author_sort Morton, Kate
collection PubMed
description BACKGROUND: People with genetic predispositions to cancer are faced with complex health decisions about managing their risk. Decision aids can support informed, values-based decisions, alongside shared decision-making with a clinician. Whilst diagnoses of genetic predispositions to cancer are increasing, there is no scalable decision aid to support these people. This paper presents an accessible, relevant decision aid template which can be adapted for different predispositions to cancer. METHODS: The decision aid template was co-developed with 12 patients affected by cancer and informed by empirical and theoretical literature. In addition, consultations were conducted with a further 19 people with Lynch syndrome; a specific genetic predisposition to cancer. Clinical stakeholders were consulted regularly. Coulter's framework for decision aid development guided the process, and these activities were complemented by the International Patient Decision Aid Standards, and the latest evidence on communicating risk in decision aids. Programme theory was developed to hypothesise how the decision aid would support decision-making and contextual factors which could influence the process. Guiding principles co-developed with the patient panel described how the decision aid could effectively engage people. RESULTS: The in-depth co-design process led to the identification of five core components of an accessible decision aid template for people with a genetic predisposition to cancer: defining the decision; a table showing implications of each option; optional further details such as icon arrays to show tailored risk and personal narratives; values clarification activity; and a summary to facilitate discussion with a clinician. Specific guidance was produced describing how to develop each component. The guiding principles identified that the decision aid template needed to promote trust, reduce distress, and be comprehensive, personally relevant and accessible in order to engage people. CONCLUSION: Adopting a co-design process helped ensure that the decision aid components were relevant and accessible to the target population. The template could have widespread application through being adapted for different genetic predispositions. The exact content should be co-designed with people from diverse backgrounds with lived experience of the specific predisposition to ensure it is as useful, engaging and relevant as possible.
format Online
Article
Text
id pubmed-9743799
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97437992022-12-13 Person-based co-design of a decision aid template for people with a genetic predisposition to cancer Morton, Kate Kohut, Kelly Turner, Lesley Smith, Sian Crosbie, Emma J. Ryan, Neil Grimmett, Chloe Eccles, Diana M. Foster, Claire Front Digit Health Digital Health BACKGROUND: People with genetic predispositions to cancer are faced with complex health decisions about managing their risk. Decision aids can support informed, values-based decisions, alongside shared decision-making with a clinician. Whilst diagnoses of genetic predispositions to cancer are increasing, there is no scalable decision aid to support these people. This paper presents an accessible, relevant decision aid template which can be adapted for different predispositions to cancer. METHODS: The decision aid template was co-developed with 12 patients affected by cancer and informed by empirical and theoretical literature. In addition, consultations were conducted with a further 19 people with Lynch syndrome; a specific genetic predisposition to cancer. Clinical stakeholders were consulted regularly. Coulter's framework for decision aid development guided the process, and these activities were complemented by the International Patient Decision Aid Standards, and the latest evidence on communicating risk in decision aids. Programme theory was developed to hypothesise how the decision aid would support decision-making and contextual factors which could influence the process. Guiding principles co-developed with the patient panel described how the decision aid could effectively engage people. RESULTS: The in-depth co-design process led to the identification of five core components of an accessible decision aid template for people with a genetic predisposition to cancer: defining the decision; a table showing implications of each option; optional further details such as icon arrays to show tailored risk and personal narratives; values clarification activity; and a summary to facilitate discussion with a clinician. Specific guidance was produced describing how to develop each component. The guiding principles identified that the decision aid template needed to promote trust, reduce distress, and be comprehensive, personally relevant and accessible in order to engage people. CONCLUSION: Adopting a co-design process helped ensure that the decision aid components were relevant and accessible to the target population. The template could have widespread application through being adapted for different genetic predispositions. The exact content should be co-designed with people from diverse backgrounds with lived experience of the specific predisposition to ensure it is as useful, engaging and relevant as possible. Frontiers Media S.A. 2022-11-23 /pmc/articles/PMC9743799/ /pubmed/36518561 http://dx.doi.org/10.3389/fdgth.2022.1039701 Text en © 2022 Morton, Kohut, Turner, Smith, Crosbie, Ryan, Grimmett, Eccles, Foster and The CanGene CanVar Patient Reference Panel, The International Lynch Decision Aid Stakeholder (LDAS) Panel. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Digital Health
Morton, Kate
Kohut, Kelly
Turner, Lesley
Smith, Sian
Crosbie, Emma J.
Ryan, Neil
Grimmett, Chloe
Eccles, Diana M.
Foster, Claire
Person-based co-design of a decision aid template for people with a genetic predisposition to cancer
title Person-based co-design of a decision aid template for people with a genetic predisposition to cancer
title_full Person-based co-design of a decision aid template for people with a genetic predisposition to cancer
title_fullStr Person-based co-design of a decision aid template for people with a genetic predisposition to cancer
title_full_unstemmed Person-based co-design of a decision aid template for people with a genetic predisposition to cancer
title_short Person-based co-design of a decision aid template for people with a genetic predisposition to cancer
title_sort person-based co-design of a decision aid template for people with a genetic predisposition to cancer
topic Digital Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743799/
https://www.ncbi.nlm.nih.gov/pubmed/36518561
http://dx.doi.org/10.3389/fdgth.2022.1039701
work_keys_str_mv AT mortonkate personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT kohutkelly personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT turnerlesley personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT smithsian personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT crosbieemmaj personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT ryanneil personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT grimmettchloe personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT ecclesdianam personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT fosterclaire personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer
AT personbasedcodesignofadecisionaidtemplateforpeoplewithageneticpredispositiontocancer